Primary Record
Capstat
- In stock
- 7,247 g
- Purity
- 98.2 %
- CAS
- 37280-35-6
Compound Identifiers & Properties
- CAS
- 37280-35-6
- PubChem CID
- 135564597
- SMILES
- C1CNC(=N[C@H]1[C@H]2C(=O)NC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N/C(=C\NC(=O)N)/C(=O)N2)CNC(=O)C[C@H](CCCN)N)CO)N)N
- Canonical SMILES
- NCCC[C@H](N)CC(=O)NC[C@@H]1NC(=O)[C@H](CO)NC(=O)[C@@H](N)CNC(=O)[C@H]([C@H]2CCNC(N)=N2)NC(=O)/C(=C/NC(N)=O)NC1=O
Names & Synonyms
- Capstat
- CAPREOMYCIN IA
- Antibiotic 29275
- Antibiotic A-250-II
- UNII-4AUQ151IUH
- AC1MHUZK
- 4AUQ151IUH
- CAPREOMYCIN IA [MI]
- RefChem:123293
- A-250-II
- CAPREOMYCIN IA [WHO-IP]
- DTXSID90891323
- BRN 1208708
- CHEMBL4464082
- DTXCID501030479
- C25H44N14O8
- C25-H44-N14-O8
- CID3032940
- LS-48801
- 37280-35-6
- (3S)-3,6-DIAMINO-N-(((2S,5S,8Z,11S,15S)-15-AMINO-11-((4R)-2-AMINO-1,4,5,6-TETRAHYDROPYRIMIDIN-4-YL)-8-((CARBAMOYLAMINO)METHYLENE)-2-(HYDROXYMETHYL)-3,6,9,12,16-PENTAOXO-1,4,7,10,13-PENTAAZACYCLOHEXADECAN-5-YL)METHYL)HEXANAMIDE
- CYCLO(3-(((3S)-3,6-DIAMINO-1-OXOHEXYL)AMINO)-L-ALANYL-(2Z)-3-((AMINOCARBONYL)AMINO)-2,3-DIDEHYDROALANYL-(2S)-2-((4R)-2-AMINO-1,4,5,6-TETRAHYDRO-4-PYRIMIDINYL)GLYCYL-(2S)-2-AMINO-.BETA.-ALANYL-L-SERYL)
- (3R)-3,6-diamino-N-(((2S,5S,8Z,11S,15S)-15-amino-11-((6R)-2-amino-1,4,5,6-tetrahydropyrimidin-6-yl)-8-((carbamoylamino)methylidene)-2-(hydroxymethyl)-3,6,9,12,16-pentaoxo-1,4,7,10,13-pentazacyclohexadec-5-yl)methyl)hexanamide
- (3R)-3,6-Diamino-N-(((2S,5S,8Z,11S,15S)-15-amino-3,6,9,12,16-pentahydroxy-8-(((C-hydroxycarbonimidoyl)amino)methylidene)-2-(hydroxymethyl)-11-((4R)-2-imino-1,3-diazinan-4-yl)-1,4,7,10,13-pentaazacyclohexadeca-1(16),3,6,9,12-pentaen-5-yl)methyl)hexanimidate
- (3R)-3,6-diamino-N-[[(2S,5S,8Z,11S,15S)-15-amino-11-[(6R)-2-amino-1,4,5,6-tetrahydropyrimidin-6-yl]-8-[(carbamoylamino)methylidene]-2-(hydroxymethyl)-3,6,9,12,16-pentaoxo-1,4,7,10,13-pentazacyclohexadec-5-yl]methyl]hexanamide
- (3R)-3,6-Diamino-N-{[(2S,5S,8Z,11S,15S)-15-amino-3,6,9,12,16-pentahydroxy-8-{[(C-hydroxycarbonimidoyl)amino]methylidene}-2-(hydroxymethyl)-11-[(4R)-2-imino-1,3-diazinan-4-yl]-1,4,7,10,13-pentaazacyclohexadeca-1(16),3,6,9,12-pentaen-5-yl]methyl}hexanimidate
- (3S)-3,6-diamino-N-[[(2S,5S,8Z,11S,15S)-15-amino-11-[(6R)-2-amino-1,4,5,6-tetrahydropyrimidin-6-yl]-8-[(carbamoylamino)methylidene]-2-(hydroxymethyl)-3,6,9,12,16-pentaoxo-1,4,7,10,13-pentazacyclohexadec-5-yl]methyl]hexanamide
- (3S)-3,6-DIAMINO-N-{[(2S,5S,8Z,11S,15S)-15-AMINO-11-[(4R)-2-AMINO-3,4,5,6-TETRAHYDROPYRIMIDIN-4-YL]-8-[(CARBAMOYLAMINO)METHYLIDENE]-2-(HYDROXYMETHYL)-3,6,9,12,16-PENTAOXO-1,4,7,10,13-PENTAAZACYCLOHEXADECAN-5-YL]METHYL}HEXANAMIDE
- 3,6-Diamino-hexanoic acid {(2S,5S,11S,15S)-15-amino-2-hydroxymethyl-11-(2-imino-hexahydro-pyrimidin-4-yl)-3,6,9,12,16-pentaoxo-8-[1-ureido-meth-(Z)-ylidene]-1,4,7,10,13-pentaaza-cyclohexadec-5-ylmethyl}-amide
- CYCLO(3-(((3S)-3,6-DIAMINO-1-OXOHEXYL)AMINO)-L-ALANYL-(2Z)-3-((AMINOCARBONYL)AMINO)-2,3-DIDEHYDROALANYL-(2S)-2-((4R)-2-AMINO-1,4,5,6-TETRAHYDRO-4-PYRIMIDINYL)GLYCYL-(2S)-2-AMINO-BETA-ALANYL-L-SERYL)